Title
Carfilzomib in Combination with Bendamustine and dexamethasone in Refractory or Relapsed Multiple MyelomaOverview / Summary
Study details
Patient eligibility criteria
Relapsed or refractory multiple myeloma after failure of two or more treatment regimens.